Napabucasin

DB12155InvestigationalSmall molecule

Napabucasin has been investigated for the treatment of Colorectal Carcinoma.

Chemical structure of Napabucasin
Formula / weight
C14H8O4 · 240.214 g/mol (avg)
Code names
BBI-608

Resolves to

Compound
UNIIZ1HHM49K7OCAS83280-65-3ChEMBLCHEMBL64130PubChem10331844
Structure
InChIKeyDPHUWDIXHNQOSY-UHFFFAOYSA-NSMILESCC(=O)C1=CC2=C(O1)C(=O)C1=CC=CC=C1C2=O
Targets
P40763STAT3

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
23Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Napabucasin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In